EXHIBIT 23.1


               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statement 
(Form S-8 No. 333-42533) pertaining to the 1995 Stock Option Plan of Titan 
Pharmaceuticals, Inc., as amended and restated, of our report dated February 
12, 1999, with respect to the consolidated financial statements of Titan 
Pharmaceuticals, Inc. included in the Annual Report (Form 10-K) for the year 
ended December 31, 1998.

                                       /s/ Ernst & Young LLP

Palo Alto, California
March 29, 1999